Thank you
This live web event has ended. Thank you for attending.
Description
![](https://bluesky_portal_prod.s3.amazonaws.com/uploads/redactor_images/1709585189.0494723_AZ-CT_logo_copy.jpg)
Liquid Biopsy and Concurrent
Testing Strategies for Patients
with Metastatic NSCLC
Why should you register now for this webinar?
- Hear a national thought leader discuss the impact of liquid biopsy and concurrent biomarker testing for the appropriate care of patients with NSCLC
- Brought to you by: CAP TODAY
- Moderated by: Bob McGonnagle, Publisher, CAP TODAY
- Presenter: Zin Htway, PhD
What will this webinar empower you to do?
- Review the potential benefits of integrating liquid biopsy with standard-of-care tissue testing on turnaround time and identification of patients with actionable biomarkers in metastatic NSCLC
- Explore patient case scenarios that demonstrate potential successes and implementation considerations for concurrent liquid biopsy integration in metastatic NSCLC
![](https://bluesky_portal_prod.s3.amazonaws.com/uploads/redactor_images/1709587150.3467016_powered-by-oncolens-logo-2.png)
CAP TODAY does not endorse any of the products or services named within. This webinar is sponsored by AstraZeneca in partnership with OncoLens.